Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02242760 · ClinicalTrials.gov registry record · Phase 2
P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris
A Phase 2 study, sponsored by Novan.
- Completed
- Registry status
- Phase 2
- Development phase
- 213
- Enrollment target
NCT02242760: Completed Phase 2 study, sponsored by Novan.
NCT02242760 is a Phase 2 study that has completed, run by Novan. The registered enrollment target is 213 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (60% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02242760, a Phase 2 study, has completed, sponsored by Novan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 213 participants
- Enrollment target
Study Summary
This is a randomized, multi-center, double-blinded study in subjects with moderate to severe acne vulgaris. Subjects eligible to enroll will be treated once or twice daily with 2 concentrations of a topical drug in development or a vehicle. Subjects will be treated for up to 12 weeks.
Primary Outcome
Change in inflammatory lesion count from Baseline to Week 12
Interventions
- DRUG Vehicle Gel
- DRUG SB204 4%
- DRUG SB204 2%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-08 |
| Phase | Phase 2 |
What the finished NCT02242760 record still lists
NCT02242760 is an interventional study that assigns participants to a tested intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (60% higher).
The record links to 0 conditions, and to 3 interventions - of which Vehicle Gel is the first listed.
NCT02242760 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02242760 about?
NCT02242760 is a clinical study titled "P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris". This is a randomized, multi-center, double-blinded study in subjects with moderate to severe acne vulgaris. Subjects eligible to enroll will be treated once or twice daily with 2 concentrations of a topical drug in development or a vehicle. Subjects will be treated for up to 12 weeks.
What is the current status of trial NCT02242760?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 213 participants. The study started on 2014-11. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02242760?
The interventions under investigation include: Vehicle Gel (DRUG), SB204 4% (DRUG), SB204 2% (DRUG).
Who is sponsoring clinical trial NCT02242760?
This trial is sponsored by Novan, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02242760's enrollment target sits among peer trials
213 290th of 2000 higher than 1,711 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06476886 · 213 participants · NA
Intensive Crisis Intervention
- NCT06544655 · 213 participants · Phase 1
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
- NCT07186816 · 213 participants · NA
SUpport From PEeRs to Expand Access Study - Community
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia